Pro Medicus (Pro Medicus) Marketable Securities : $21.93 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Pro Medicus Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Pro Medicus's Marketable Securities for the quarter that ended in Dec. 2023 was $21.93 Mil.

Pro Medicus's annual Marketable Securities increased from Jun. 2021 ($15.12 Mil) to Jun. 2022 ($18.90 Mil) and increased from Jun. 2022 ($18.90 Mil) to Jun. 2023 ($20.30 Mil).

Pro Medicus Marketable Securities Historical Data

The historical data trend for Pro Medicus's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus Marketable Securities Chart

Pro Medicus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Marketable Securities

Get a 7-Day Free Trial

15.12

18.90

20.30

Pro Medicus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Marketable Securities	Get a 7-Day Free Trial															13.75	18.90	19.61	20.30	21.93

Pro Medicus Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Pro Medicus (OTCPK:PMCUF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Pro Medicus Marketable Securities Related Terms

Thank you for viewing the detailed overview of Pro Medicus's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pro Medicus (Pro Medicus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (OTCPK:PMCUF) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

PMC:Germany PME:Australia

Address

450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121

Website

https://www.promed.com.au

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.